| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 08/29/2002 | WO2002066494A2 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade |
| 08/29/2002 | WO2002066175A1 Calibrator for calibrating a light beam |
| 08/29/2002 | WO2002066162A1 Method for the preparation of optical (bio)chemical sensor devices |
| 08/29/2002 | WO2002066135A1 A microchip electrospray device and column with affinity adsorbents and use of the same |
| 08/29/2002 | WO2002066110A1 Blood collection systems and methods that derive estimated effects upon the donor's blood volume and hematocrit |
| 08/29/2002 | WO2002066077A2 Modulated release particles for aerosol delivery |
| 08/29/2002 | WO2002066073A1 Method of examining effect of angionegesis inhibitor mediated by the inhibition of integrin expression |
| 08/29/2002 | WO2002066067A2 Albumin-based drug delivery system and antimicrobial peptides |
| 08/29/2002 | WO2002066063A1 Remedies for metabolic bone diseases |
| 08/29/2002 | WO2002066045A2 Methods for modulating an immune response by modulating the interaction between ctla4 and pp2a |
| 08/29/2002 | WO2002066032A1 Treatment of schizophrenia |
| 08/29/2002 | WO2002066028A2 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids |
| 08/29/2002 | WO2002065943A2 Ocular tear growth factor-like protein |
| 08/29/2002 | WO2002065912A1 Device and method for measuring urin conductivity |
| 08/29/2002 | WO2002065893A2 Photochemical amplified immunoassay |
| 08/29/2002 | WO2002065889A1 Method for examining cell and tissue samples |
| 08/29/2002 | WO2002050538A3 Sea-trosy and related methods |
| 08/29/2002 | WO2002050108A3 Immunogenic glycopeptides, screening, preparation and uses |
| 08/29/2002 | WO2002048676A3 Multiple array system for integrating bioarrays |
| 08/29/2002 | WO2002046752A9 Optical determination of glucose utilizing boronic acid adducts |
| 08/29/2002 | WO2002041992A3 Method for biochemical analysis and corresponding arrangement |
| 08/29/2002 | WO2002038759A3 Method for inducing apoptiosis |
| 08/29/2002 | WO2002038032A3 Methods and devices for collecting and processing mammary fluid |
| 08/29/2002 | WO2002037209A3 System, method, and computer software product for linked window interfaces |
| 08/29/2002 | WO2002036624A3 Methods, compositions and therapeutic applications relating to fortilin (= translationally controlled tumor protein, tctp) and modulators thereof |
| 08/29/2002 | WO2002034392A3 Vessel centering system and method |
| 08/29/2002 | WO2002033112A3 Protein-protein interactions in neurodegenerative diseases |
| 08/29/2002 | WO2002031481A3 Device and method for electrically accelerated immobilisation and detection of molecules |
| 08/29/2002 | WO2002024942A3 Adp-glucose receptor |
| 08/29/2002 | WO2002024235A3 Prochelators of radiometal labeled molecules |
| 08/29/2002 | WO2002020723A3 Compositions and methods for targeting peptides in humans in vivo |
| 08/29/2002 | WO2002014857A3 Direct selection of protein complexes relevant to the physiological or diagnostic context of a biological specimen |
| 08/29/2002 | WO2002012880A3 Powder dispensing/collection manifold for indoor wear testing |
| 08/29/2002 | WO2002010403A3 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme |
| 08/29/2002 | WO2002008241A3 Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same |
| 08/29/2002 | WO2002006788A3 Electrochemical method for measuring chemical reaction rates |
| 08/29/2002 | WO2002002774A3 32626, a human udp-glycosyltransferase and uses thereof |
| 08/29/2002 | WO2001096547A3 Human kinases |
| 08/29/2002 | WO2001096018A3 Apparatus and method for evaluating a test fluid |
| 08/29/2002 | WO2001090758A3 Diagnosis of alzheimer's disease ldl receptor protein-1 |
| 08/29/2002 | WO2001085952A3 Modified inosine 5'-monophosphate dehydrogenase polypeptides and uses thereof |
| 08/29/2002 | WO2001085944A3 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 08/29/2002 | WO2001083751A3 Methods for binding an exogenous molecule to cellular chromatin |
| 08/29/2002 | WO2001082975A3 Membrane-permeant peptide complexes for medical imaging |
| 08/29/2002 | WO2001081930A3 Reagent and method for "serum iron" assay in plasma |
| 08/29/2002 | WO2001079846A3 Diagnostic assay for endometriosis |
| 08/29/2002 | WO2001079844A3 Multi-analyte diagnostic test for thyroid disorders |
| 08/29/2002 | WO2001077686A3 Cellular calcium responce for diagnosis of alzheimer's disease |
| 08/29/2002 | WO2001077667A3 Polymeric food spoilage sensor |
| 08/29/2002 | WO2001077338A3 Human protein kinases and protein kinase-like enzymes |
| 08/29/2002 | WO2001073437A3 Antigen-specific enzyme-linked immunosorbent assay |
| 08/29/2002 | WO2001071342A3 Identification of mast cell/basophil activation inhibitors |
| 08/29/2002 | WO2001069228A3 Mis hydrogen sensors |
| 08/29/2002 | WO2001068848A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/29/2002 | WO2001062975A3 Pyrophosphorolysis activated polymerization (pap): application to allele-specific amplification and nucleic acid sequence determination |
| 08/29/2002 | WO2001062960A3 Method for detecting cytosine methylation in dna samples |
| 08/29/2002 | WO2001061055A3 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes |
| 08/29/2002 | WO2001060408A3 Microcompetiton and human disease |
| 08/29/2002 | WO2001042462A9 Phospholipase a2 inhibitory peptides from python reticulatus |
| 08/29/2002 | WO2001040293A9 Method of modulating proapoptotic and antiapoptotic pathways in cells |
| 08/29/2002 | WO2001020019A9 Implantable glucose sensor |
| 08/29/2002 | WO2001011359A9 Color space analysis in biochemical and immunological assays |
| 08/29/2002 | WO2001009204A3 Controlled-architecture polymers and use thereof as separation media |
| 08/29/2002 | WO2001007481A9 Antitumor antibodies, proteins, and uses thereof |
| 08/29/2002 | WO2001005427A9 Psca: prostate stem cell antigen and uses thereof |
| 08/29/2002 | WO2001004629A9 E4orf4 and pp2a polypeptides, modulators, and mimetics for selectively inducing cell death |
| 08/29/2002 | WO2001001148A9 Method for determining the fertility of mammals, especially humans |
| 08/29/2002 | WO2000077518A9 Methods and compositions for opsonophagocytic assays |
| 08/29/2002 | WO2000072020A9 Microscale diffusion immunoassay |
| 08/29/2002 | WO2000072004A9 Method of determining the three-dimensional shape of a macromolecule |
| 08/29/2002 | WO2000068382A9 PrP-LIKE GENE |
| 08/29/2002 | WO2000060120A9 Methods of detecting microorganism using immobilized probes |
| 08/29/2002 | WO2000056866A9 Akt-3 nucleic acids, polypeptides, and uses thereof |
| 08/29/2002 | WO2000053735A9 Methods for identifying modulators of synaptic plasticity and cell motility |
| 08/29/2002 | WO2000036400A9 Device and method for preliminary testing a neat serum sample in a primary collection tube |
| 08/29/2002 | WO2000034475A9 Grnf4, a gdnf-related neurotrophic factor |
| 08/29/2002 | WO2000034474A9 Growth factor homolog zvegf3 |
| 08/29/2002 | WO2000031306A9 Multiplex amplification of short tandem repeat loci |
| 08/29/2002 | WO2000023569A9 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 08/29/2002 | WO1999064055A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors |
| 08/29/2002 | WO1999060014A9 Methods and compounds for modulating nuclear receptor coactivator binding |
| 08/29/2002 | WO1999057280A9 Neisseria meningitidis antigens and compositions |
| 08/29/2002 | WO1999030130A3 Method for investigating or structuring a surface layer |
| 08/29/2002 | US20020120952 Liquid reagent for calcium assay |
| 08/29/2002 | US20020120950 A homogenous cell mixture spontaneously sorting to form discrete first and second layers, e.g. keratinocytes and fibroblasts, and having a connective tissue component; skin grafts: testing a response to a chemical or a drug |
| 08/29/2002 | US20020120947 Protein-protein interactions in neurodegenerative disorders |
| 08/29/2002 | US20020120526 Novel amplicon in the 20q13 region of human chromosome 20 and uses thereof |
| 08/29/2002 | US20020120426 Degradation diagnostic method, degradation diagnostic mediation device and degradation diagnostic device and computer-readable recording medium on which a program is recorded |
| 08/29/2002 | US20020120410 Apparatus and method for analyzing liquid absorbency/desorbency, pore volume distribution and in-plane wicking/absorption |
| 08/29/2002 | US20020120404 Methods and apparatus for mass fingerprinting of biomolecules |
| 08/29/2002 | US20020120189 Electromagnetic analyzer of anisotropy in chemical organized systems |
| 08/29/2002 | US20020120141 Dye labeled imidazoquinoline compounds |
| 08/29/2002 | US20020120127 Replica amplification of nucleic acid arrays |
| 08/29/2002 | US20020120126 Making and using immobilized arrays of nucleic acids; improve the efficiency of multiplex polymerase chain reaction (PCR) using arrays of immobilized nucleic acids |
| 08/29/2002 | US20020120123 Human vascular endothelial growth factor 2 |
| 08/29/2002 | US20020120121 Antisense therapy of cancer; Inhibitors of Apoptosis Proteins (IAPs) and an additional related antiapoptotic protein, NAIP; |
| 08/29/2002 | US20020120107 Monoclonal antibody recognizing phosphatidylinositol-3,4,5-triphosphate |
| 08/29/2002 | US20020120103 17 human secreted proteins |
| 08/29/2002 | US20020120100 Peptide transporters that specifically target certain cell types for the delivery of drugs and therapeutic agents |
| 08/29/2002 | US20020120008 Life extension of drosophila by a drug treatment |